[2 MIN READ]
This article is part of a paid branded content series with Get Creative, a division of USA Today. The article originally appeared on USA Today here.
Hear the latest news in gynecologic cancer treatments and research at a free virtual speaker series presented by Providence Foundations of Oregon and Providence Cancer Institute.
It’s Gynecologic Cancer Awareness Month, so take the time to learn more about ovarian, endometrial/uterine, vulvar and vaginal cancer prevention.
Providence hematology expert offers the most updated information about lymphoma, treatment options and helpful community resources.
New investigator-initiated clinical trial available only at Providence Cancer Institute will evaluate the safety and efficacy of targeted therapy combination for treating thyroid cancer.
Providence experts share their insights on recent advances in melanoma research and care, and tips on communicating with loved ones in a live virtual symposium on Oct. 7.
New Providence-sponsored study may provide new insights into the efficacy of shorter duration radiation and chemotherapy treatment before surgery for people with stage II/III rectal cancer
Results of a phase II clinical trial shows that adding an immunotherapy pill to standard pre-surgery treatment of colorectal cancer patients doubled the successful outcomes.
Two early phase trials testing the safety and tolerability of new medications may help people with sarcomas, lymphomas and other cancers.
Twin sisters Kerrie and Kristine face breast cancer and a genetic risk of stomach cancer together.
UV ray exposure contributes to millions of skin cancer cases each year. Learn how to protect your skin to reduce your sunburn and skin cancer risks.
Dr. Jianguo Huang to lead the Preclinical Cancer Therapy Laboratory with a focus on bridging sarcoma research and immunotherapy
Providence researcher awarded National Institutes of Health grant to lead a new lab focusing on the discovery of novel inflammatory pathways in cancer that are targets for therapeutic intervention.
Learn about the health benefits of a traditional Asian diet at this free, online education event presented by Providence Cancer Institute and the Asian Health & Service Center.
Leading healthcare professionals interested in the treatment of patients with neuroendocrine tumors to gather in June for a comprehensive medical conference held in Oregon.
Although skin protection is important year-round, the summer is a good time to review helpful tips and tricks to help keep your skin safe while you enjoy the outdoors.
Two investigator-initiated trials sponsored by the Earle A. Chiles Research Institute are currently recruiting patients with either advanced HER2-positive or HR positive/HER2 negative breast cancer.
Providence researchers recruit adult patients with solid cancers for phase I clinical trial of genetically engineered, adoptively transferred T cells.
Adoptive cell therapy study at Providence Cancer Institute gives hope to woman with metastatic pancreatic cancer. Results may lead to new treatments and longer lives for people with advanced cancers.
A Florida woman with advanced pancreatic cancer is hopeful after receiving an experimental treatment in a clinical trial at Providence Cancer Institute that shrunk her tumors.
Ovarian Cancer Alliance and Providence Cancer Institute to host free education event on June 29 for ovarian cancer patients and their caregivers.
